Exyte Group
Exyte concludes financial year 2018 with record results and expects further growth
DGAP-News: Exyte Group / Key word(s): Annual Results Exyte concludes financial year 2018 with record results and expects further growth – Record sales of EUR 3.5 billion (+48%) – Rise in order intake to EUR 4.4 billion (+35%) – Adj. EBIT at EUR 170 million (+57%) – Outlook for 2019: rising sales and sustained development of adj. EBIT Exyte AG (“Exyte”), a global leader in the design, engineering and construction of high-tech facilities, continued on its profitable growth path and clearly achieved its objectives in the financial year 2018. The company generated sales of EUR 3.5 billion in 2018, resulting in a growth of more than 48% compared to the previous year (2017: EUR 2.4 billion). Order intake at Exyte increased by 35% to EUR 4.4 billion in 2018 (2017: EUR 3.2 billion). Adjusted EBIT improved more than forecasted and rose to EUR 170 million in the past year (2017: EUR 108 million), which corresponds to an adjusted EBIT margin of 4.8%. “We generated a record result in 2018 and will continue on our path for sustained profitable growth. This positive development is confirmation that our strategic realignment and focus on clearly defined target markets and core regions is paying off, and that we are on the right track with our customer-oriented approach,” Dr. Wolfgang Büchele (CEO) said. “Exyte’s key growth driver remains our Advanced Technology Facilities (ATF) segment, in which we serve customers in the semiconductor industry. Meanwhile, we are also benefiting from the continued growth in demand for highly efficient manufacturing environments for semiconductor production. A key driver of our business is the volume development of produced wafers and chips, which has been growing steadily by 7% to 8% per year over the course of the past years.” While the Advanced Technology Facilities segment (semiconductors specifically) remains Exyte’s strongest business segment, with total sales of EUR 2.8 billion, sales also developed well in the two other strategic business segments, Life Sciences and Chemicals (pharmaceuticals and biotechnology in particular) and Data Center. Exyte was once again able to grow at a regional level, with a 59% year-on-year increase in sales in the Asia-Pacific (APAC) region, which made up over half of the company’s total sales. At the same time, Exyte was also able to generate a substantial year-on-year increase in sales in Europe (EMEA) (+78%). Significant increase in workforce Exyte continues to benefit from key global trends Outlook for 2019: Exyte expects strong demand Exyte’s CEO, Dr. Wolfgang Büchele, had this to say on the goals for the 2019 financial year: “Overall, we believe we are well-positioned in our core business segments and target markets, which are marked by global growth trends. Our focus for 2019 is to further expand our strong market position in all of our core business segments.” About Exyte
30.04.2019 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English |
Company: | Exyte Group |
Loewentorbogen 9b | |
70376 Stuttgart | |
Germany | |
EQS News ID: | 804835 |
End of News | DGAP News Service |